|
Volumn 51, Issue 9, 2000, Pages 1182-1183
|
Obtaining informed consent of patients at risk of nueroleptic malignant syndrome
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
ADULT;
ARTICLE;
HIGH RISK PATIENT;
HUMAN;
INFORMED CONSENT;
NEUROLEPTIC MALIGNANT SYNDROME;
PSYCHIATRIST;
TARDIVE DYSKINESIA;
CLINICAL APPROACH/SOURCE;
EMPIRICAL APPROACH;
MENTAL HEALTH THERAPIES;
PROFESSIONAL PATIENT RELATIONSHIP;
ADULT;
ANTIPSYCHOTIC AGENTS;
ATTITUDE OF HEALTH PERSONNEL;
CANADA;
DISCLOSURE;
FEMALE;
HUMANS;
INFORMED CONSENT;
MALE;
NEUROLEPTIC MALIGNANT SYNDROME;
PSYCHIATRY;
QUESTIONNAIRES;
RISK FACTORS;
|
EID: 0033851377
PISSN: 10752730
EISSN: None
Source Type: Journal
DOI: 10.1176/appi.ps.51.9.1182 Document Type: Article |
Times cited : (2)
|
References (10)
|